311 related articles for article (PubMed ID: 25856691)
21. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
Liu T; Liu D; Guan S; Dong M
Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
[TBL] [Abstract][Full Text] [Related]
22. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
[TBL] [Abstract][Full Text] [Related]
23. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
24. [Circulating MicroRNAs as Biomarkers of Colorectal Cancer].
Umemura T; Kuroki C
Rinsho Byori; 2015 Mar; 63(3):336-46. PubMed ID: 26524857
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
26. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis.
Zuo Z; Jiang Y; Zeng S; Li Y; Fan J; Guo Y; Tao H
Pathol Res Pract; 2020 Oct; 216(10):153130. PubMed ID: 32853954
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
Wang C; Zhao K; Rong Q
Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
[TBL] [Abstract][Full Text] [Related]
29. Examining plasma microRNA markers for colorectal cancer at different stages.
Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W
Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633
[TBL] [Abstract][Full Text] [Related]
30. Limited diagnostic value of microRNAs for detecting colorectal cancer: a meta-analysis.
Zhou XJ; Dong ZG; Yang YM; Du LT; Zhang X; Wang CX
Asian Pac J Cancer Prev; 2013; 14(8):4699-704. PubMed ID: 24083729
[TBL] [Abstract][Full Text] [Related]
31. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
Wan J; Wu W; Che Y; Kang N; Zhang R
Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
[TBL] [Abstract][Full Text] [Related]
32. Circulating microRNAs as novel biomarkers in the diagnosis of prostate cancer: a systematic review and meta-analysis.
Yin C; Fang C; Weng H; Yuan C; Wang F
Int Urol Nephrol; 2016 Jul; 48(7):1087-95. PubMed ID: 27068818
[TBL] [Abstract][Full Text] [Related]
33. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
[TBL] [Abstract][Full Text] [Related]
34. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
35. Rare circulating microRNAs as biomarkers of colorectal neoplasia.
Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW
PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of microRNA-17 as a potential biomarker in diagnosis of colorectal cancer.
Liu T; Yin L; Yan G; Li C; Wang L
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):86-93. PubMed ID: 29808806
[TBL] [Abstract][Full Text] [Related]
37. Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.
Zi Y; Yin Z; Xiao W; Liu X; Gao Z; Jiao L; Deng L
Mol Neurobiol; 2015 Dec; 52(3):1494-1503. PubMed ID: 25367880
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
[TBL] [Abstract][Full Text] [Related]
39. Identification of microRNAs as novel biomarkers for glioma detection: a meta-analysis based on 11 articles.
Qu S; Guan J; Liu Y
J Neurol Sci; 2015 Jan; 348(1-2):181-7. PubMed ID: 25510379
[TBL] [Abstract][Full Text] [Related]
40. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
